Oslo Metropolitan University
Also known as: Akerhus University Hospital | Akershus Dermatological Centre | Akershus universitetssykehus | Akershus Universitetssykehus HF | Akershus University | Akershus University College | Akershus University Hospital, Norway | Clinical Trial Unit (CTU), Oslo University Hospital | Dep of Anesethesiology, Akershus University Hospital | Dep. of Neurology, Akershus University Hospital | Dept Neurology, Akershus University Hospital, Norway | Joe Chan | Lars Tanum | Oslo and Akershus University College of Applied Sciences | Oslo Metropolitan University | Torbjorn Omland | University Hospital, Akershus
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2004Last known activity
Sep 15, 2025
Timeline
1960s
- Jan 1, 1961
Oslo Metropolitan University— Founded
Drugs by trial phase (87 distinct, 67 trials)
Phase 4 (22 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
Phase 2 (35 own, 0 via acquisition)
Other trials (16 own, 0 via acquisition)
Indications
Studied for
- Aortic Valve Insufficiency
- Asthma
- Back Pain
- Brain Diseases
- Breast Neoplasms
- Central Nervous System Diseases
- Cognition Disorders
- Cognitive Dysfunction
- Colorectal Neoplasms
- Contracture
- Coronavirus Infections
- Crohn Disease
- Dementia
- Depression
- Depressive Disorder
- Disease
- Dupuytren Contracture
- Glucose Intolerance
- Glucose Metabolism Disorders
- Hepatitis
- Hepatitis C
- Hepatitis C, Chronic
- Hypersensitivity
- Hypertension
- Infections
- Inflammation
- Insulin Resistance
- Low Back Pain
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Mental Disorders
- Metabolic Diseases
- Migraine Disorders
- Multiple Myeloma
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Nervous System Diseases
- Neurocognitive Disorders
- Opioid-Related Disorders
- Parkinson Disease
- Pathologic Processes
- Pneumonia
- Pregnancy Complications
- Pulmonary Disease, Chronic Obstructive
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Respiratory Sounds
- Respiratory Tract Infections
- Sclerosis
- Severe Acute Respiratory Syndrome
- Small Cell Lung Carcinoma
- Testicular Neoplasms
- Thrombocytopenia
- Thrombosis
- Venous Thrombosis
- Ventricular Remodeling
- Virus Diseases
Recent trials (50)
- NCT07051915CollaboratorPhase 3Sep 15, 2025
- NCT06712641Sponsor investigatorPhase 4Jun 30, 2025
- NCT06712641Lead sponsorPhase 4Jun 30, 2025
- NCT06839820Lead sponsorN/AFeb 1, 2025
- NCT06839820Sponsor investigatorN/AFeb 1, 2025
- NCT06839820OfficialN/AFeb 1, 2025
- NCT06362707CollaboratorPhase 2Aug 1, 2024
- NCT06248671OfficialPhase 2May 1, 2024
- NCT06485336OfficialPhase 2May 1, 2024
- NCT06248671CollaboratorPhase 2May 1, 2024
- NCT06485336CollaboratorPhase 2May 1, 2024
- NCT06162013CollaboratorPhase 2Jan 31, 2024
- NCT05705115CollaboratorPhase 4Jan 1, 2024
- NCT06020716CollaboratorPhase 4Aug 16, 2023
- NCT05732051Overall official - principal investigatorPhase 2Mar 16, 2023
Details
- Founded
- Lørenskog, NO Jan 1, 1961
- Last known activity
- Sep 15, 2025
Notes
--- Notes from Akershus University: --- Pre-folding founded info: 1994-01-01 Kjeller None Norway https://en.wikipedia.org/wiki/Akershus_University_College --- --- --- Pre-folding founded info: 2018-01-12 Oslo None Norway https://en.wikipedia.org/wiki/Oslo_Metropolitan_University ---